E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma

Oncogene
José Carlos MachadoManuel Sobrinho-Simões

Abstract

In diffuse gastric carcinoma, despite common E-cadherin gene (CDH1) mutations, tumors show absence of CDH1 loss of heterozigosity (LOH) in most cases. This observation challenges the classical two-hit model of tumor suppressor gene inactivation. In order to investigate whether or not CDH1 promoter methylation may function as the second hit we analysed a series of 23 sporadic gastric carcinomas for the presence of CDH1 mutations, CDH1 promoter methylation, LOH and E-cadherin expression. CDH1 mutations were detected in nine of the 16 (56.3%) diffuse gastric carcinomas and in none of the seven intestinal gastric carcinomas. In diffuse gastric carcinomas harboring CDH1 mutations, LOH was observed in a single case. Loss of plasma membrane E-cadherin expression was consistently found in all nine cases with CDH1 mutation, suggesting that tumors inactivated the remaining CDH1 allele via a different mechanism. CDH1 promoter methylation was observed in nine of the 16 (56.3%) diffuse-type gastric carcinoma cases, including six of the nine cases (66.7%) harboring CDH1 mutations. CDH1 promoter methylation was also seen in two (28.6%) intestinal-type cases. Our results show that CDH1 promoter methylation is the second hit in more than half o...Continue Reading

References

Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Apr 16, 1998·Nature·P GuilfordA E Reeve
Sep 23, 1998·Human Mutation·G BerxF van Roy
Aug 5, 2000·International Journal of Cancer. Journal International Du Cancer·S IidaY Yuasa
Dec 29, 2000·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·D E PathmanD H Taylor

❮ Previous
Next ❯

Citations

Jul 12, 2011·Inflammatory Bowel Diseases·Suzanne van SommerenRinse K Weersma
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Bas A J VerhageJack A Schalken
Dec 6, 2005·Virchows Archiv : an International Journal of Pathology·Erika RosivatzMario Sarbia
Nov 12, 2005·Journal of Cancer Research and Clinical Oncology·Tamara CacevSanja Kapitanović
Dec 14, 2011·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Rajini SeevaratnamLucy Helyer
Jul 11, 2006·Clinical & Experimental Metastasis·Yu YuechengXin Xiaoyan
Nov 30, 2007·Familial Cancer·Kasmintan A SchraderDavid G Huntsman
Jun 11, 2009·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Rohit R SharmaKevin K Roggin
Sep 6, 2012·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Luigina GraziosiStefano Fiorucci
Jan 26, 2011·Medical Oncology·Kaixiong TaoGuobin Wang
Jul 13, 2004·Cancer Treatment Reviews·Mario ScartozziStefano Cascinu
Aug 13, 2013·Trends in Molecular Medicine·Salomé S PinhoCelso A Reis
Nov 5, 2002·The American Journal of Pathology·Erika RosivatzKarl-Friedrich Becker
May 28, 2003·Cancer Letters·Hiromasa TsukinoTakahiko Katoh
Feb 8, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Teresa L MastracciIrene L Andrulis
Sep 6, 2008·Human Molecular Genetics·Joana Simões-CorreiaGianpaolo Suriano
Oct 13, 2011·Human Molecular Genetics·António Carlos FerreiraJosé Carlos Machado
May 12, 2010·Cold Spring Harbor Perspectives in Biology·Geert Berx, Frans van Roy
Jan 5, 2012·Cold Spring Harbor Perspectives in Biology·Eduard Batlle, David G Wilkinson
Jul 31, 2007·Journal of Medical Genetics·S MasciariD Huntsman
Jan 1, 2004·Hereditary Cancer in Clinical Practice·Carla OliveiraRaquel Seruca
Aug 20, 2011·PloS One·Joana FigueiredoRaquel Seruca
Dec 13, 2006·Future Oncology·Amber YasmeenAla-Eddin Al Moustafa
Apr 3, 2014·Genome Biology·Yeon-Su LeeJin Soo Lee
May 24, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B CarvalhoR Seruca
Sep 13, 2014·Inflammatory Bowel Diseases·Declan F McCole
Dec 3, 2014·Best Practice & Research. Clinical Gastroenterology·Hugo PinheiroFátima Carneiro
Feb 11, 2014·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Yukie YodaToshikazu Ushijima
Mar 10, 2012·Journal of Gastroenterology·Eiji OkiYoshihiko Maehara
Aug 21, 2013·Expert Opinion on Therapeutic Targets·Patrícia CarneiroRaquel Seruca
Dec 1, 2012·Surgical Pathology Clinics·Rhonda K Yantiss, Wade S Samowitz
Nov 26, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Giovanni CorsoFranco Roviello
Nov 9, 2010·Annales de pathologie·Magali Svrcek
Oct 13, 2010·Infectious Disease Clinics of North America·M Blanca PiazueloPelayo Correa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.